Literature DB >> 9796568

Isolated nasopharyngeal Hodgkin's disease presenting as nasal obstruction.

D D Malis1, D Moffat, G W McGarry.   

Abstract

Lymphomas are the second most frequent malignancy affecting the head and neck. Within head and neck lymphomas, Hodgkin's disease accounts for only 10-35% of all cases; 70-80% of Hodgkin's disease of the head and neck involves nodal tissue, with extranodal Hodgkin's disease being most often found in the tissues of Waldeyer's ring. Extranodal Hodgkin's disease of the head and neck that does not involve Waldeyer's ring is extremely rare. We report a case of isolated extranodal Hodgkin's disease of the nasopharynx who presented to the rhinology clinic with symptoms of nasal obstruction. This unusual site, the possible reasons for its rarity and the investigations and management are discussed with reference to the literature.

Entities:  

Mesh:

Year:  1998        PMID: 9796568

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  4 in total

1.  Lymphocyte Depleted Hodgkin's Lymphoma Presented with Haemolytic Anemia: A Case Report and Literature Review.

Authors:  Ravinder Singh; Soheyl Sheikh; Shambulingappa Pallagatti; Amit Aggarwal; Deepak Gupta; Roopika Handa; Gaurav Goyal; Raman Kumar
Journal:  J Maxillofac Oral Surg       Date:  2013-05-05

Review 2.  Hodgkin Lymphoma of the Nasopharynx: Case Report with Review of the Literature.

Authors:  Adepitan A Owosho; Casey E Gooden; Alden G McBee
Journal:  Head Neck Pathol       Date:  2015-02-03

3.  [Tumor of the nasopharyngeal wall. Hodgkin lymphoma (Hodgkin disease), nodular sclerosis, grade 1, stage Ia, primary manifestation of the nasopharyngeal wall].

Authors:  C Herrmann; C Koitschev; E Kaiserling; S Preyer
Journal:  HNO       Date:  2002-05       Impact factor: 1.284

4.  Primary extranodal, extralymphatic hodgkin lymphoma of the mandible.

Authors:  Guido Ricardo Gonzalez-Fontal; Joaquin D Rosales; Roberto Jaramillo; Andres F Henao-Martinez
Journal:  Case Rep Med       Date:  2011-06-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.